Clinical Trial Update: A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands [Phase 1]

View source ↗

Summary

Phase I trial evaluating whether different doses of FlutiForm affect adrenal cortisol production in asthma patients; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FlutiForm (fluticasone propionate/formoterol)

Snippet

Sponsor: SkyePharma AG | Conditions: Asthma | Phase 1 | Status: COMPLETED